TRT and hair loss: what the evidence actually shows
Quick answer
TRT increases circulating testosterone, which elevates the substrate available for 5-alpha reductase conversion to DHT, a potent androgen that accelerates follicular miniaturization in genetically predisposed men. The degree of DHT elevation depends partly on delivery method, with transdermal formulations generally producing higher DHT-to-testosterone ratios than intramuscular injections. Finasteride can mitigate DHT-related hair loss but requires monitoring on TRT because inhibiting 5-alpha reductase shifts testosterone availability toward aromatization, potentially elevating estradiol.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @legertreatments actually say?
The creator acknowledged that hair loss on TRT "can happen" and correctly pointed to the conversion of testosterone into dihydrotestosterone (DHT) as the mechanism. They also flagged finasteride as something to be cautious about, saying it "can have implications for your testosterone treatment." That last point is where things get genuinely interesting, and somewhat incomplete.
To their credit, the creator didn't oversell the risk or promise hair loss is inevitable. The framing was cautious and hedged. But the finasteride warning was left hanging without real explanation, which could leave viewers either too scared to consider it or completely confused about why it matters.
Does the science back this up?
Yes, mostly. The DHT pathway is well-established. Testosterone is converted to DHT by the enzyme 5-alpha reductase, primarily in hair follicles and the prostate. In men genetically predisposed to androgenetic alopecia, DHT binds to androgen receptors in scalp follicles and triggers miniaturization over time. This is not controversial.
What TRT does is increase circulating testosterone, which means more substrate available for that conversion. A 2016 review by Blumeyer et al. in the Journal of the German Society of Dermatology confirmed that elevated androgens can accelerate genetically predisposed hair loss, but do not cause it in men without the genetic predisposition. So "accelerate" is the right word. The creator used it correctly.
The wrinkle is that DHT levels on TRT vary significantly depending on the delivery method. A 2010 study by Swerdloff et al. published in the Journal of Clinical Endocrinology and Metabolism found that testosterone gels produce higher DHT-to-testosterone ratios than injections, which is a clinically meaningful difference for men worried about scalp effects.
What did they get wrong (or right)?
The DHT explanation was accurate. Credit where it is due. But the finasteride comment deserves more scrutiny. The creator said to "be cautious" because finasteride "can have implications for your testosterone treatment." That is technically true but so vague it is almost misleading by omission.
Here is what actually happens: finasteride blocks 5-alpha reductase, which reduces DHT but also shifts the testosterone-to-estrogen ratio. When DHT conversion is inhibited, more testosterone becomes available for aromatization into estradiol. For men on TRT, this can mean elevated estrogen levels, which carries its own set of side effects including water retention, mood changes, and in some cases gynecomastia. That is the "implication" the creator was gesturing at. Saying it plainly would have been more useful than the vague caution.
There is also a broader concern worth naming. The Post-Finasteride Syndrome debate, while still contested in the literature, has been reported in case series and has a dedicated registry. The FDA updated finasteride labeling in 2012 to include persistent sexual side effects. Dismissing finasteride as simply having "implications for testosterone treatment" undersells a legitimate risk profile that patients deserve to understand fully.
What should you actually know?
If you are on TRT and worried about hair loss, a few things are worth understanding before your next appointment.
- Your genetic predisposition matters more than your TRT dose. If you have no family history of androgenetic alopecia, elevated testosterone is unlikely to trigger significant hair loss.
- DHT levels on TRT are not uniform. Delivery method matters. Gels and creams tend to produce higher DHT relative to testosterone than intramuscular injections. If hair retention is a priority, this is worth discussing with your prescriber.
- Finasteride is not automatically off the table on TRT, but it requires careful monitoring of estradiol and testosterone levels. It should not be added without clinical oversight and regular bloodwork.
- Topical finasteride and topical minoxidil have emerging evidence for preserving hair with lower systemic absorption, which may reduce the hormonal interaction risk. A 2021 study by Randolph and Bhatt in the Journal of Drugs in Dermatology reviewed topical finasteride as a lower-risk option for men on hormonal therapy.
The creator's instinct to flag finasteride was correct. The execution left too much unsaid for a patient trying to make an informed decision.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT and hair loss: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
TRT and hair loss: what the evidence actually shows should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
TRT increases circulating testosterone, which elevates the substrate available for 5-alpha reductase conversion to DHT, a potent androgen that accelerates follicular miniaturization in genetically predisposed men.
FormBlends verdict
TRT increases circulating testosterone, which elevates the substrate available for 5-alpha reductase conversion to DHT, a potent androgen that accelerates follicular miniaturization in genetically predisposed men. The degree of DHT elevation depends partly on delivery method, with transdermal formulations generally producing higher DHT-to-testosterone ratios than intramuscular injections. Finasteride can mitigate DHT-related hair loss but requires monitoring on TRT because inhibiting 5-alpha reductase shifts testosterone availability toward aromatization, potentially elevating estradiol.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- TRT increases circulating testosterone, which elevates the substrate available for 5-alpha reductase conversion to DHT, a potent androgen that accelerates follicular miniaturization in genetically predisposed men. The degree of DHT elevation depends partly on delivery method, with transdermal formulations generally producing higher DHT-to-testosterone ratios than intramuscular injections. Finasteride can mitigate DHT-related hair loss but requires monitoring on TRT because inhibiting 5-alpha reductase shifts testosterone availability toward aromatization, potentially elevating estradiol.
- DHT, not testosterone itself, is the primary driver of androgenetic alopecia. TRT raises testosterone levels, which increases available substrate for DHT conversion via 5-alpha reductase.
- Genetic predisposition is the key variable. Men without family history of pattern baldness face substantially lower risk of TRT-accelerated hair loss.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- DHT, not testosterone itself, is the primary driver of androgenetic alopecia. TRT raises testosterone levels, which increases available substrate for DHT conversion via 5-alpha reductase.
- Genetic predisposition is the key variable. Men without family history of pattern baldness face substantially lower risk of TRT-accelerated hair loss.
- Delivery method affects DHT levels. A 2010 Swerdloff et al. study (Journal of Clinical Endocrinology and Metabolism) found transdermal testosterone produces higher DHT-to-testosterone ratios than intramuscular injections.
- Finasteride blocks DHT but increases estradiol conversion on TRT. Any addition of finasteride to a TRT protocol should involve estradiol monitoring and prescriber oversight.
- Topical finasteride may offer a lower systemic-exposure option for hair retention. Randolph and Bhatt (2021, Journal of Drugs in Dermatology) reviewed topical formulations as potentially safer for men on hormonal therapy.
- The FDA updated finasteride labeling in 2012 to include persistent sexual side effects. This is part of the risk conversation that should happen before adding it to any TRT protocol.
- The creator's core claim that TRT accelerates rather than directly causes hair loss is supported by the literature. The finasteride warning was correct in direction but needed more clinical detail to be genuinely useful.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Leger Treatments · TikTok creator
1.5K views on this video
Does TRT cause hair loss? 💉💬 It’s a common question we get asked from patients considering Testosterone Replacement Therapy (TRT). 💡 The short answer: TRT doesn’t directly cause hair loss — but it can accelerate it in those who are genetically predisposed to male pattern baldness. This happens due to increased levels of DHT, a hormone derived from testosterone that can impact hair follicles. Have more TRT-related questions? Drop them in the comments — we’re here to help. 👇 #trt #tes
Not medical advice. This video was made by Leger Treatments, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.